Abstract:Abstract: The tumor suppressor protein p53, a transcription factor playing a key role in cancer prevention, interacts with DNA as its primary means of determining cell fate in the event of DNA damage. When it becomes mutated, it opens damaged cells to the possibility of reproducing unchecked, which can lead to formation of cancerous tumors. Despite its critical role, therapies at the molecular level to restore p53 native function remain elusive, due to its complex nature. Nevertheless, considerable information has been amassed, and new means of investigating the problem have become available. Objectives: We consider structural, biophysical, and bioinformatic insights and their implications for the role of direct and indirect readout and how they contribute to binding site recognition, particularly those of low consensus. We then pivot to consider advances in computational approaches to drug discovery. Materials and methods: We have conducted a review of recent literature pertinent to the p53 protein. Results: Considerable literature corroborates the idea that p53 is a complex allosteric protein that discriminates its binding sites not only via consensus sequence through direct H-bond contacts, but also a complex combination of factors involving the flexibility of the binding site. New computational methods have emerged capable of capturing such information, which can then be utilized as input to machine learning algorithms towards the goal of more intelligent and efficient de novo allosteric drug design. Conclusions: Recent improvements in machine learning coupled with graph theory and sector analysis hold promise for advances to more intelligently design allosteric effectors that may be able to restore native p53-DNA binding activity to mutant proteins. Clinical relevance: The ideas brought to light by this review constitute a significant advance that can be applied to ongoing biophysical studies of drugs for p53, paving the way for the continued development of new methodologies for allosteric drugs. Our discoveries hold promise to provide molecular therapeutics which restore p53 native activity, thereby offering new insights for cancer therapies. Graphical abstract: Structural representation of the p53 DBD (PDBID 1TUP). DNA consensus sequence is shown in gray, and the protein is shown in blue. Red beads indicate hotspot residue mutations, green beads represent DNA interacting residues, and yellow beads represent both.

Single Molecule Study of the Weak Biological Interactions Between P53 and Dna

Label-Free Detection of the P53-DNA Complex

In Situ Monitoring of P53 Protein and MDM2 Protein Interaction in Single Living Cells Using Single-Molecule Fluorescence Spectroscopy.

Navigating the complexity of p53-DNA binding: implications for cancer therapy

A single-molecule characterization of p53 search on DNA

Molecular dynamics-based computational investigations on the influence of tumor suppressor p53 binding protein against other proteins/peptides

Real-time Surface Plasmon Resonance Monitoring of Site-Specific Phosphorylation of P53 Protein and Its Interaction with MDM2 Protein.

Nanoplasmonic Tweezers Visualize Protein p53 Suppressing Unzipping of Single DNA-Hairpins

Comparison of the Protein-Protein Interfaces in the P53-Dna Crystal Structures: Towards Elucidation of the Biological Interface.

P53-MDM2 interaction monitoring and inhibitors potency evaluation based on CRISPR-Cas12a sensing platform

Interactions between PHD3-Bromo of MLL1 and H3K4me3 Revealed by Single-Molecule Magnetic Tweezers in a Parallel DNA Circuit.

Progressing Single Biomolecule Force Spectroscopy Measurements for the Screening of Dna Binding Agents

Full-atomistic Molecular Dynamics Analysis of p53 Active Tetramer

Conformational Stability and Dynamics of the Cancer‐associated Isoform Δ133p53β Are Modulated by P53 Peptides and P53‐specific DNA

Sensitive and Selective Detection of the P53 Gene Based on a Triple-Helix Magnetic Probe Coupled to a Fluorescent Liposome Hybridization Assembly Via Rolling Circle Amplification.

Sensitive biosensor for p53 DNA sequence based on the photothermal effect of gold nanoparticles and the signal amplification of locked nucleic acid functionalized DNA walkers using a thermometer as readout

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

Integration of Exonuclease III-assisted Recycling Amplification and Multi-Site Enzyme Polymerization Labeling for Sensitive Detection of P53 Gene

Protein-Protein Interaction Monitoring and Inhibitors Potency Evaluation Based on Crispr-Cas12a Sensing Platform

Probing the origin of structural stability of single and double stapled p53 peptide analogs bound to MDM2

Ultrasensitive Label-Free Amplified Colorimetric Detection of P53 Based on G-quadruplex MBzymes.